This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bellone, G. Articles by Rodeck, U. Search for Related Content PubMed PubMed Citation Articles by Bellone, G. Articles by Rodeck, U.

Production and Pro-Apoptotic Activity of Soluble CD95 Ligand in Pancreatic Carcinoma¹

Department of Clinical Physiopathology, University of Torino, 10126 Torino, Italy [G. B., C. S., A. C., K. M., L. D., G. E.]; Medicosurgical Department of the Digestive Tract and Nutritional Diseases, Azienda Ospedaliera San Giovanni Battista, Molinette, 10126 Torino, Italy [E. C. F.]; Department of Medical Sciences, University "A. Avogadro" of Eastern Piedmont, 28100 Novara, Italy [O. A., G. V.]; Department of Dermatology and Cutaneous Biology and Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 [U. R.]

We report here that the progression of pancreatic carcinomas in tumor patients is associated with increased serum levels of both the soluble forms of CD95 ligand (CD95L/FasL) and its receptor, CD95 (Fas). Shedding of proteolytically processed soluble CD95L was also observed in pancreatic carcinoma cells in vitro, thus identifying one possible source of CD95L in patients’ sera. Because the secreted forms of both CD95 and CD95L have been implicated previously in protection of cells from CD95-mediated cell death, we assessed the effect of soluble CD95L in supernatants of pancreatic carcinoma cells on viability of Jurkat T lymphocytes. We describe that (a) supernatants derived from cultured pancreatic carcinoma cells caused apoptosis of Jurkat cells; (b) soluble tumor-derived CD95L contributed significantly to this effect; and (c) in comparison to Jurkat cells, pancreatic carcinoma cells themselves revealed increased resistance to apoptosis induction by autocrine soluble CD95L. These results are consistent with the notion that in the microenvironment of pancreatic tumors, tumor-derived shed CD95L exerts paracrine pro-apoptotic effects. In addition, because it is released at high levels into the bloodstream, soluble CD95L may have systemic effects in tumor patients that reach beyond the microenvironment of the tumor site.

This article has been cited by other articles:

				C Brockschmidt, H Hirner, N Huber, T Eismann, A Hillenbrand, G Giamas, B Radunsky, O Ammerpohl, B Bohm, D Henne-Bruns, et al. Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo Gut, June 1, 2008; 57(6): 799 - 806. [Abstract] [Full Text] [PDF]

				C. Nadal, J. Maurel, R. Gallego, A. Castells, R. Longaron, M. Marmol, S. Sanz, R. Molina, M. Martin-Richard, and P. Gascon FAS/FAS Ligand Ratio: A Marker of Oxaliplatin-Based Intrinsic and Acquired Resistance in Advanced Colorectal Cancer Clin. Cancer Res., July 1, 2005; 11(13): 4770 - 4774. [Abstract] [Full Text] [PDF]